PRESS RELEASE published on 06/25/2025 at 18:00, 7 months 10 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC indicating a decrease in shareholding below the threshold. The biopharmaceutical company is focused on therapeutic innovation and clinical research technologies Technology Clinical Research Transparency Notification Biopharmaceutical Oxurion NV
BRIEF published on 06/19/2025 at 08:35, 7 months 17 days ago Oxurion to Acquire Preclinical Microbiology CRO in Toulouse Acquisition Diversification Toulouse Oxurion Microbiology CRO
BRIEF published on 06/19/2025 at 08:35, 7 months 17 days ago Oxurion acquiert une CRO en microbiologie préclinique à Toulouse Acquisition Diversification Toulouse Oxurion CRO En Microbiologie
PRESS RELEASE published on 06/19/2025 at 08:30, 7 months 17 days ago Oxurion ondertekent intentieverklaring voor de voorgenomen overname van een preklinische microbiologie-CRO om zich te diversifiëren en zijn aanwezigheid in de regio Toulouse te versterken Oxurion NV, een biofarmaceutisch bedrijf in Leuven, kondigt intentieovereenkomst voor de overname van onderneming gespecialiseerd in microbiologische diensten aan, ter versterking van expertise en strategie Stratégie Overname Oxurion NV Biofarmaceutisch Microbiologische Diensten
PRESS RELEASE published on 06/19/2025 at 08:30, 7 months 17 days ago Oxurion signs a letter of intent for the planned acquisition of a preclinical microbiology CRO to diversify and strengthen its presence in the Toulouse region Oxurion NV announces LOI to acquire 70% share capital of preclinical microbiology services company. Economic details of the transaction and growth projections disclosed Acquisition Transaction Details Growth Projections Oxurion NV Preclinical Microbiology
PRESS RELEASE published on 06/19/2025 at 08:30, 7 months 17 days ago Oxurion signe une lettre d'intention pour l'acquisition projetée d'une CRO de services précliniques en microbiologie afin de se diversifier et de renforcer sa présence en région toulousaine Oxurion NV signe une lettre d'intention pour l'acquisition de 70% d'une société spécialisée en microbiologie appliquée à la santé humaine et animale, dermocosmétiques et nutraceutiques Acquisition Biopharmaceutique Lettre D'intention Oxurion NV Microbiologie Appliquée
BRIEF published on 06/18/2025 at 18:05, 7 months 17 days ago Oxurion Announces Transparency Notification from Atlas Special Opportunities II LLC Transparency Notification Biopharmaceutical Atlas Special Opportunities Ownership Structure Oxurion
BRIEF published on 06/18/2025 at 18:05, 7 months 17 days ago Oxurion annonce une notification de transparence de la part d'Atlas Special Opportunities II LLC Biopharmaceutique Notification De Transparence Oxurion Opportunités Spéciales Atlas Structure De Propriété
PRESS RELEASE published on 06/18/2025 at 18:00, 7 months 17 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV announces receipt of transparency notification from Atlas Special Opportunities II, LLC regarding shareholding. Company combines therapeutic innovation with technology for clinical research Clinical Research Transparency Notification Biopharmaceutical Belgium Oxurion NV
PRESS RELEASE published on 06/18/2025 at 18:00, 7 months 17 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC, verlaagt aandeel tot onder drempel 20%. Biofarmaceutisch bedrijf in Leuven kondigt belangrijke ontwikkeling aan Transparantiekennisgeving Oxurion NV Biofarmaceutisch België Atlas Special Opportunities II LLC
Published on 02/06/2026 at 08:00, 2 hours 12 minutes ago Caledonia Mining Corporation Plc Non-Executive Director Shareholding Notification
Published on 02/06/2026 at 03:50, 6 hours 22 minutes ago High Tide Resources annonce des placements privés sans courtier
Published on 02/06/2026 at 02:45, 7 hours 27 minutes ago High Tide Resources annonce des placements privés sans courtier
Published on 02/06/2026 at 00:57, 9 hours 15 minutes ago Noram Lithium Announces Closing of Fully Allocated Non-Brokered Financing
Published on 02/06/2026 at 00:00, 10 hours 12 minutes ago LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
Published on 02/06/2026 at 09:40, 32 minutes ago Ferrero Group reports Consolidated Financial Statements for the 2024/2025 Financial Year
Published on 02/06/2026 at 09:00, 1 hour 12 minutes ago Original-Research: 123fahrschule SE (von NuWays AG): BUY
Published on 02/06/2026 at 09:00, 1 hour 12 minutes ago Original-Research: tonies SE (von NuWays AG): BUY
Published on 02/06/2026 at 07:54, 2 hours 18 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026
Published on 02/05/2026 at 19:15, 14 hours 57 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/05/2026 at 19:15, 14 hours 57 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JANVIER 2026